Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
Actual shortage: | 251 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-BICALUTAMIDE | 50MG | TABLET | Resolved | 2022-11-14 | 2023-04-28 | 174616 |
TEVA-HYDROCHLOROTHIAZIDE | 25MG | TABLET | Resolved | 2022-12-01 | 2023-01-26 | 176758 |
TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176761 |
TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176764 |
TEVA-EMTEC-30 | 30MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-04-27 | 176773 |
TEVA-RISPERIDONE | 4MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176782 |
TEVA-ATOVAQUONE PROGUANIL | 100MG 250MG | TABLET | Resolved | 2022-12-01 | 2022-12-15 | 176785 |
TEVA-PRAZOSIN | 2MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176803 |
TEVA-PRAZOSIN | 5MG | TABLET | Actual shortage | 2022-12-01 | 2023-12-21 | 176806 |
ACT FLUCONAZOLE | 50MG | TABLET | Resolved | 2022-12-01 | 2023-10-04 | 176809 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176812 |
SEASONALE | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176815 |
TEVA-BUPRENORPHINE/NALOXONE | 2MG 8MG | TABLET | Resolved | 2022-12-01 | 2022-12-22 | 176824 |
TEVA-ERLOTINIB | 150MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176830 |
TEVA-LENOLTEC NO. 1 | 8MG 15MG 300MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176833 |
TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
TEVA-SUMATRIPTAN DF | 100MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176845 |
TEVA-DOXAZOSIN | 1MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176857 |
PORTIA 21 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177502 |
PORTIA 28 | 0.03MG 0.15MG | TABLET | Resolved | 2022-12-08 | 2022-12-22 | 177505 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-QUETIAPINE | 100MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64846 |
TEVA-QUETIAPINE | 25MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64849 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64855 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64858 |
TEVA-ENALAPRIL | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64861 |
TEVA-ENALAPRIL | 16MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64866 |
TEVA-ENALAPRIL | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64869 |
TEVA-LISINOPRIL (TYPE P) | 5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64909 |
NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
TEVA-HYDROMORPHONE | 1MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64970 |
TEVA-HYDROMORPHONE | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64975 |
TEVA-HYDROMORPHONE | 4MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64983 |
TEVA-HYDROMORPHONE | 8MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64993 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |